Internal Medicine

Almost 20% of young people with autism spectrum disorder (ASD) also were diagnosed with depression in a study that tracked participants into their 20s.

BioLyte Laboratories is voluntarily recalling lots of their topical gel at risk of possible microbial contamination can result in increased infections that may require medical intervention and could be potentially life threatening to certain individuals.

Patients with asthma and eosinophilia have thicker airway nerves, according to new research.

Addressing housing arrangements during a medical visit may be as important as addressing blood pressure or blood sugar levels.

A new meta-analysis aimed to quantify the effect, if any, of physician burnout on patient wellbeing. They found the links are strong and consequential.

A study of primary care patients found that of patients screened for alcohol use, just 2.4% were also screened for depression. Men and racial/ethnic minorities were less likely to be screened for depression.

A daily dose of aspirin could reduce HIV transmission rates by reducing inflammation and thus the number of HIV target cells in the female genital tract.

New research says it’s medically possible to use HCV-positive patients as liver donors. Now, a new study finds it’s also cost-effective.

High Impact Chronic Pain encompasses individuals with chronic pain who also have a disability. Data collected in this study will help improve care for patients with HICP and guide future research.

Stay up to date on the latest product recalls issued by the FDA this past week.

Study of abrupt versus gradual reduction of nicotine informs FDA-proposed rule on reducing cigarette nicotine to "minimally addictive" levels.

Implementation of antimicrobial stewardship programs in outpatient dialysis centers reduce infections caused by multidrug-resistant organisms, including Clostridium difficile.

The New Drug Application is based on data from 5 phase 3 studies of the efficacy and safety of esketamine nasal spray for treatment-resistant depression.

The treatment may be most appropriate for toddlers who are admitted to the hospital, have severe allergies, or are seen in the emergency department.

The results of a recent study revealed that the implementation of a comprehensive care plan for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) can be successful in reducing both readmission and mortality rates.

The results of a recent study indicate that combination DAA regimens that include sofosbuvir are effective for achieving SVR in patients with chronic hepatitis C virus and compensated liver cirrhosis.

Investigators found associations between ART and ISTI-based regimens and increased viral suppression rates across the United States.

New recommendations from the CDC's Advisory Committee on Immunization Practices reveal that health care providers have the intranasally-administered live attenuated influenza vaccine (LAIV) among their arsenal of available vaccines for the 2018-2019 flu season.

A new study has found that, based on the complexities of the EHR system they're required to use, physicians have a nearly equal chance of shortening or extending their career.

One Cleveland Clinic practitioner describes his real-world experience with the use of mepolizumab in patients with severe eosinophilic asthma.

In 2016, US firearm suicides represented 35.3% of all global firearm suicides—despite the US just comprising 4.3% of the global population.

As more physicians are caring for transgender patients, many are finding they are unprepared and they lack the training, skills, and resources to do so, according to the authors of a recent review article.

A new survey found that Clostridium difficile infections have a substantial impact on the health-related quality of work, work life, and physical activity of those who are infected.

The first darunavir-based single tablet regimen for HIV has shown positive results in trials as both a switch therapy and for the rapid initiation of treatment in those who are newly diagnosed.

The Kala Pharmaceuticals therapy INVELTYS becomes the first twice-daily ocular corticosteroid indicated for such treatment.